Heterogeneous nuclear RNA promotes synthesis of (2',5')oligoadenylate and is cleaved by the (2',5')oligoadenylate-activated endoribonuclease.
Heterogeneous nuclear RNA contains double-stranded regions that are not found in mRNA and that may serve as recognition elements for processing enzymes. The double-stranded regions of heterogeneous nuclear RNA prepared from HeLa cells promoted the synthesis of (2',5')oligoadenylate [(2',5')oligo(A) or (2'5')An] when incubated with (2',5')An polymerase. This enzyme is present in elevated levels in interferon-treated cells, and labeled heterogeneous nuclear RNA incubated with extracts of these cells is preferentially cleaved, since mRNA included in the same incubations is not appreciably degraded. The cleavage of heterogenous nuclear RNA is caused by the synthesis of (2'5')An and by a "localized" activation of the (2',5')An-dependent endonuclease, since it was enhanced by ATP, the substrate of the (2',5')An polymerase, and inhibited by 2'-dATP and ethidium bromide. Both of these compounds suppress the synthesis of (2',5')An, the first by competitive inhibition and the latter by intercalating into double-stranded RNA. The possible role of double-stranded regions and of the (2',5')An polymerase-endonuclease system in the processing of heterogeneous nuclear RNA is discussed.
D015088:2',5'-Oligoadenylate Synthetase; D000227:Adenine Nucleotides / Q000096:biosynthesis*; D000255:Adenosine Triphosphate / Q000494:pharmacology; D003838:Deoxyadenine Nucleotides / Q000494:pharmacology; D004720:Endonucleases / Q000494:pharmacology; D004996:Ethidium / Q000494:pharmacology; D006367:HeLa Cells / Q000378:metabolism; D006801:Humans; D007372:Interferons / Q000494:pharmacology; D009713:Nucleotidyltransferases / Q000378:metabolism; D009841:Oligonucleotides / Q000096:biosynthesis*; D009843:Oligoribonucleotides / Q000096:biosynthesis*; D012330:RNA, Double-Stranded / Q000378:metabolism; D012332:RNA, Heterogeneous Nuclear / Q000378:metabolism*; D012333:RNA, Messenger / Q000378:metabolism; D043244:Ribonuclease III; D012260:Ribonucleases / Q000494:pharmacology
D000227:Adenine Nucleotides; D003838:Deoxyadenine Nucleotides; D009841:Oligonucleotides; D009843:Oligoribonucleotides; D012330:RNA, Double-Stranded; D012332:RNA, Heterogeneous Nuclear; D012333:RNA, Messenger; C023505:2',5'-oligoadenylate; D000255:Adenosine Triphosphate; D007372:Interferons; D009713:Nucleotidyltransferases; D015088:2',5'-Oligoadenylate Synthetase; D004720:Endonucleases; D012260:Ribonucleases; D043244:Ribonuclease III; D004996:Ethidium; C026600:2'-deoxyadenosine triphosphate